Trial Condition(s):

Ovulation inhibition

Ovulation inhibition of two 4-phasic oral contraceptive regimens

Bayer Identifier:

91271

ClinicalTrials.gov Identifier:

NCT00805415

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The aim of the study is to investigate the ovulation inhibition of two 4-phasic oral contraceptive regimens.

Inclusion Criteria
- Healthy women willing to use non-hormonal methods of contraception
Exclusion Criteria
- Women with any contraindication for oral contraceptive use, for example but not limited to: presence or history of venous or arterial thrombotic / thrombembolic events, hypertension, presence or history of severe hepatic disease

Trial Summary

Enrollment Goal
209
Trial Dates
black-arrow
Phase
2
Could I receive a placebo?
No
Products
Natazia/Qlaira (EV/DNG, BAY86-5027)
Accepts Healthy Volunteers
Yes

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Dinox GmbH Berlin

Berlin, Germany, 10115

Status
Completed
 
Locations

Dinox B.V.

Groningen, Netherlands, 9713 GZ

Status
Completed
 

Trial Design